In fact, inhibition of PI3K/Akt/mTOR proved the activation of another important pathway dysregulated in breast cancer, the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway [74]. The gene discussed is MTOR; the disease is breast carcinoma.